Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04506008 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Hypofractionated Radiotherapy Followed by Surgical Resection in the Treatment of Soft Tissue Sarcomas

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 28, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Re-verified, no change to tracked fieldsv10
  2. Primary completion date: Dec 2025 to Jun 2026 Completion date: Dec 2026 to Jun 2027v9 Show 1 more changeShow less
    • Completion date: Dec 2026 to Jun 2027
  3. Re-verified, no change to tracked fieldsv8
  4. Interventions: Hypofractionated Radiotherapy (Radiation) to Moderately-Hypo-fractionation Radiotherapy (Radiation), Questionnaire Administration (Other), Resection (Procedure)… Secondary endpoints: 5 to 1 · Study description expanded, about 61 words · Study arms: 1 to 2v7 Show 3 more changesShow less
    • Secondary endpoints: 5 to 1
    • Study description expanded, about 61 words
    • Study arms: 1 to 2

    See this version in full on ClinicalTrials.gov ↗

  5. Primary completion date: Dec 2024 to Dec 2025 Completion date: Dec 2025 to Dec 2026 · Eligibility criteria shortened, about 9 words · Study description shortened, about 1 word · 1 morev6 Show 4 more changesShow less
    • Completion date: Dec 2025 to Dec 2026
    • Eligibility criteria shortened, about 9 words
    • Study description shortened, about 1 word
    • Study title shortened, about 1 word

    See this version in full on ClinicalTrials.gov ↗

Show 4 earlier versionsHide 4 earlier versions
  1. Start date: Jan 11, 2021 to Mar 2, 2021v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Feb 2021 to Jan 11, 2021 · Site details revisedv3 Show 2 more changesShow less
    • Start date changed from estimate of Feb 2021 to Jan 11, 2021
    • Site details revised
  4. Start date: Oct 2020 to Feb 2021 Primary completion date: Sep 2024 to Dec 2024 · Completion date: Sep 2025 to Dec 2025v2 Show 2 more changesShow less
    • Primary completion date: Sep 2024 to Dec 2024
    • Completion date: Sep 2025 to Dec 2025
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The trial will use neoadjuvant hypofractionated radiotherapy followed by surgical resection in the treatment for soft tissue sarcoma. It will allow patients to be treated over a shorter course (5 or 15 days of radiation) compared to the traditional 5 week regimen. It is proposed that this will be possible without increasing the risk of wound complication or local recurrence compared with a traditional 5 week course of pre-operative radiation.
Trial Details
NCT Number NCT04506008
Lead Sponsor Vanderbilt-Ingram Cancer Center
Conditions Soft Tissue Sarcomas
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov